Skip to main content

Lung Disease

Our exceptional foundation of physicians and state-of-the-art methods, like XVIVO and intensity-modulated radiation therapy, to diagnose and treat complex lung diseases makes pulmonology care a hallmark of UF Health.

Interstitial lung disease team

At UF Health, our team of knowledgeable pulmonary physicians will decipher your underlying lung condition. The goal of the Advanced Lung Disease Program is to set you on the path to recovery by shining a light on the roadblocks in your way.

Our team will provide a quick and accurate diagnosis before devising a treatment plan to fit your needs. At UF Health, our pulmonary leaders will construct an ideal treatment plan modeled around your needs. The Advanced Lung Disease Program is equipped with an array of cutting-edge technologies and treatments aimed at producing the best possible patient outcomes. After uncovering your underlying condition, our exemplary team will employ any combination of these tools to secure those life-changing results. Our program's focus areas are adult lung cancer, adult lung transplant, and pediatric lung transplant.

Pulmonary Fibrosis patient
USNWR pulmonology and lung surgery badge 2026-2027

UF Health Shands Hospital is among the nation’s top hospitals for pulmonology and lung surgery in the U.S. News & World Report 2026-2027 Best Hospital rankings.

Quick Facts

90%

Percentage of new lung cancer referrals seen within a period of seven days

14

Clinical trials that make up one of the most comprehensive portfolios for lung cancer

3 Months

Average wait time for adult lung transplantation (national average is six months)

92.4%

Survival rate with functioning transplant after one year (above national average)

Conditions and Treatments

Our Locations

Our Experts

Independent doctors are not employed by UF Health, but may provide medical care at one of our locations.

Patient Education

Want to know more? Check out our Patient Education section for more information.

Clinical trials: Lung Disease

UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:

1305-0014 (FIBRONEERTM IPF)

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or pirfenidone for their IPF, they can continue treatment…

Investigators
Divya C Patel, Christopher Harden
Status
Accepting Candidates
Ages
40 Years - N/A
Sexes
All
1305-0023 (FIBRONEERTM ILD)

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary Fibrosis (IPF) can join the study. If they already take nintedanib, they can continue…

Investigators
Divya C Patel, Christopher Harden
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

News and patient stories: Lung Disease

ARDS patients improve with experimental treatment

June 30, 2026

JUPITER, Fla. — Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A…

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology

Joe G.N. Garcia, M.D., the study’s first author and the physician-scientist who developed ALT-100, works with a colleague in a laboratory setting.
More Lung Disease stories

Latest podcast episodes